• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

PHAR

Partnership for Health Analytic Research

  • Services
    • Real World Data: Secondary Data Analysis
    • Real World Data: Primary Data Collection
    • Evidence Synthesis
  • Publications
  • Clients
  • Team
  • News
  • Contact

Primary Sidebar

News Categories

  • Uncategorized
  • Presentations & Events
  • Awards & Recognition
  • Publications
  • News & Announcements

Archive

  • 2023
  • 2022
  • 2021
  • 2020

PHAR’s Strong Presence at ISPOR 2012-6 Posters Presented at Annual Meeting

PHAR researchers contributed to 6 posters that were presented at the 17th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Washington, DC. Poster topics ranged from PNETs to healthcare utilization and cost of uncontrolled epilepsy. A synopsis of each poster is listed below:

  • An analysis of acromegaly treatment patterns using a novel graphic method revealed patterns of treatment as well as insights about adherence and persistence in the treatment of the disease.
  • An evaluation of treatment patterns for several FDA-approved drugs for myelodysplastic syndrome showed that, among other findings, most patients are given supportive care rather than hypomethylating agents for treatment.
  • A comparison of annual overall and healthcare-related costs between adult patients with stable and uncontrolled epilepsy found that, regardless of disease stability, both are associated with a significant economic burden and that uncontrolled epilepsy is associated with greater costs.
  • A comparison of healthcare utilization between patients with stable and uncontrollable epilepsy found that patients with uncontrollable epilepsy use significantly more healthcare services.
  • An expert panel on the appropriateness of medical treatment in patients with unresectable midgut gastrointestinal neuroendocrine tumors (NETs) developed a consensus for scenarios not covered in other guidelines.
  • An expert panel facilitated by the RAND/UCLA modified Delphi process produced consensus statements on the appropriateness of medical treatment in unresectable non-midgut NETs.

June 11, 2012 | Awards & Recognition

Partnership for Health Analytic Research

Beverly Hills
Cambridge
San Francisco
info@pharllc.com
310.858.9555
pharllc.com
  • Employment
  • Contact
  • Privacy Policy
Design by Studio Rainwater
© PHAR 2023